Botox Celebrates 10th Anniversary

People have been looking younger and less wrinkled thanks to Botox for the last 10 years. April 15th marks the 10-year anniversary of the U.S. Food and Drug Administration’s approval of Botex Cosmetic (onabotulinumtoxinA).

David E.I. Pyott, Chairman of the Board, President and CEO, Allergan, Inc., said: “When approved by the FDA in 2002, Botox Cosmetic changed the way that physicians could treat patients who were interested in improving the appearance of their vertical frown lines between the brows. Botox Cosmetic has become the number-one neuromodulator in the United States.”

According to a press release, Botox was first approved by the FDA to treat two rare eye muscle disorders 22 years ago. The drug has now moved to the cosmetic world where it has been reducing frown lines for the last 10 years.

Malcolm Z. Roth, MD, president of the American Society of Plastic Surgeons, said: “The FDA approval of Botox Cosmetic enhanced the practice of plastic surgery by providing plastic surgeons with a new treatment option for patients seeking to reduce the appearance of vertical frown lines between the eyebrows.”

Botox treatments have been performed more than 11.8 million times on more than 5 million people since the drug was approved by the FDA in 2002.

Susan Weinkle, MD, president of the American Society for Dermatologic Surgery, said: “The approval of Botox Cosmetic in 2002 dramatically changed our ability to treat our patients by giving them an effective option to treat the appearance of moderate to severe vertical frown lines with a minimally invasive procedure. Botox Cosmetic has become more accepted by the public, and this treatment has brought more patients into aesthetic practices to learn about other treatments available.”


Leave a Reply

Your email address will not be published. Required fields are marked *